177 related articles for article (PubMed ID: 36560661)
1. Bovine Papillomavirus Type 1 or 2 Virion-Infected Primary Fibroblasts Constitute a Near-Natural Equine Sarcoid Model.
Hainisch EK; Jindra C; Reicher P; Miglinci L; Brodesser DM; Brandt S
Viruses; 2022 Nov; 14(12):. PubMed ID: 36560661
[TBL] [Abstract][Full Text] [Related]
2. Potential of a BPV1 L1 VLP vaccine to prevent BPV1- or BPV2-induced pseudo-sarcoid formation and safety and immunogenicity of EcPV2 L1 VLPs in horse.
Hainisch EK; Abel-Reichwald H; Shafti-Keramat S; Pratscher B; Corteggio A; Borzacchiello G; Wetzig M; Jindra C; Tichy A; Kirnbauer R; Brandt S
J Gen Virol; 2017 Feb; 98(2):230-241. PubMed ID: 28284277
[TBL] [Abstract][Full Text] [Related]
3. Genomic characterisation of bovine papillomavirus types 1 and 2 identified in equine sarcoids in Japan.
Yamashita-Kawanishi N; Chambers JK; Uchida K; Tobari Y; Yoshimura H; Yamamoto M; Yumoto N; Aoki H; Sugiura K; Higuchi T; Saito S; Haga T
Equine Vet J; 2021 Nov; 53(6):1199-1209. PubMed ID: 33300145
[TBL] [Abstract][Full Text] [Related]
4. No evidence of bovine papillomavirus type 1 or 2 infection in healthy equids.
Pratscher B; Hainisch EK; Sykora S; Brandt S; Jindra C
Equine Vet J; 2019 Sep; 51(5):612-616. PubMed ID: 30560998
[TBL] [Abstract][Full Text] [Related]
5. Epidemiologic analysis of a sarcoid outbreak involving 12 of 111 donkeys in Northern Italy.
Abel-Reichwald H; Hainisch EK; Zahalka S; Corteggio A; Borzacchiello G; Massa B; Merlone L; Nasir L; Burden F; Brandt S
Vet Microbiol; 2016 Nov; 196():85-92. PubMed ID: 27939161
[TBL] [Abstract][Full Text] [Related]
6. Evidence from a Series of 104 Equine Sarcoids Suggests That Most Sarcoids in New Zealand Are Caused by Bovine Papillomavirus Type 2, although Both BPV1 and BPV2 DNA Are Detectable in around 10% of Sarcoids.
Munday JS; Orbell G; Fairley RA; Hardcastle M; Vaatstra B
Animals (Basel); 2021 Oct; 11(11):. PubMed ID: 34827825
[TBL] [Abstract][Full Text] [Related]
7. Bovine papillomavirus type 1 (BPV1) and BPV2 are closely related serotypes.
Shafti-Keramat S; Schellenbacher C; Handisurya A; Christensen N; Reininger B; Brandt S; Kirnbauer R
Virology; 2009 Oct; 393(1):1-6. PubMed ID: 19729180
[TBL] [Abstract][Full Text] [Related]
8. Type-specific L1 virus-like particle-mediated protection of horses from experimental bovine papillomavirus 1-induced pseudo-sarcoid formation is long-lasting.
Harnacker J; Hainisch EK; Shafti-Keramat S; Kirnbauer R; Brandt S
J Gen Virol; 2017 Jun; 98(6):1329-1333. PubMed ID: 28635592
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of early and late bovine papillomavirus protein expression in equine sarcoids.
Wilson AD; Armstrong ELR; Gofton RG; Mason J; De Toit N; Day MJ
Vet Microbiol; 2013 Mar; 162(2-4):369-380. PubMed ID: 23123175
[TBL] [Abstract][Full Text] [Related]
10. Genomic sequences of bovine papillomaviruses in formalin-fixed sarcoids from Australian horses revealed by polymerase chain reaction.
Bloch N; Breen M; Spradbrow PB
Vet Microbiol; 1994 Jul; 41(1-2):163-72. PubMed ID: 7801519
[TBL] [Abstract][Full Text] [Related]
11. Localization of Bovine Papillomavirus Nucleic Acid in Equine Sarcoids.
Gaynor AM; Zhu KW; Dela Cruz FN; Affolter VK; Pesavento PA
Vet Pathol; 2016 May; 53(3):567-73. PubMed ID: 26215759
[TBL] [Abstract][Full Text] [Related]
12. Bovine papillomavirus DNA can be detected in keratinocytes of equine sarcoid tumors.
Bogaert L; Martens A; Kast WM; Van Marck E; De Cock H
Vet Microbiol; 2010 Dec; 146(3-4):269-75. PubMed ID: 21095508
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy of Equine Sarcoids-From Early Approaches to Innovative Vaccines.
Jindra C; Hainisch EK; Brandt S
Vaccines (Basel); 2023 Mar; 11(4):. PubMed ID: 37112681
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of infiltrating immune cells and bovine papillomavirus type 1 E2-positive cells in equine sarcoids.
Geisshüsler H; Marti E; Stoffel MH; Kühni K; Stojiljkovic A; von Tscharner C; Vidondo B; Gerber V; Koch C
Vet J; 2016 Oct; 216():45-52. PubMed ID: 27687925
[TBL] [Abstract][Full Text] [Related]
15. The Development of Novel Primer Sets to Specifically Amplify Each of the Five Different
Munday JS; Gedye K; Daudt C; Chaves Da Silva F
Vet Sci; 2021 Sep; 8(10):. PubMed ID: 34679038
[TBL] [Abstract][Full Text] [Related]
16. Equine Sarcoids-Causes, Molecular Changes, and Clinicopathologic Features: A Review.
Ogłuszka M; Starzyński RR; Pierzchała M; Otrocka-Domagała I; Raś A
Vet Pathol; 2021 May; 58(3):472-482. PubMed ID: 33461443
[TBL] [Abstract][Full Text] [Related]
17. Localization of Bovine papillomavirus in equine sarcoids and inflammatory skin conditions of horses using laser microdissection and two forms of DNA amplification.
Wobeser BK; Hill JE; Jackson ML; Kidney BA; Mayer MN; Townsend HG; Allen AL
J Vet Diagn Invest; 2012 Jan; 24(1):32-41. PubMed ID: 22362933
[TBL] [Abstract][Full Text] [Related]
18. Bovine papillomavirus load and mRNA expression, cell proliferation and p53 expression in four clinical types of equine sarcoid.
Bogaert L; Van Poucke M; De Baere C; Dewulf J; Peelman L; Ducatelle R; Gasthuys F; Martens A
J Gen Virol; 2007 Aug; 88(Pt 8):2155-2161. PubMed ID: 17622617
[TBL] [Abstract][Full Text] [Related]
19. Influenza virus vector iNS1 expressing bovine papillomavirus 1 (BPV1) antigens efficiently induces tumour regression in equine sarcoid patients.
Jindra C; Hainisch EK; Rümmele A; Wolschek M; Muster T; Brandt S
PLoS One; 2021; 16(11):e0260155. PubMed ID: 34797850
[TBL] [Abstract][Full Text] [Related]
20. Detection of bovine papillomavirus DNA on the normal skin and in the habitual surroundings of horses with and without equine sarcoids.
Bogaert L; Martens A; De Baere C; Gasthuys F
Res Vet Sci; 2005 Dec; 79(3):253-8. PubMed ID: 16054896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
